A STUDY ON RECENT TRENDS IN CARDIO-DIABETIC MANAGEMENT

Under the Guidance of:- Presented By :-

Mrs. Nidhi Verma Vishal Sharma

Faculty, PCTE MBA 2C

Ludhiana

PHARMACEUTICAL INDUSTRY

Introduction

History Advantage to India Growth Scenario

MOREPEN LABORATORIES LTD.

VisionTo be a Global pharmaceutical player with strong

R&Dsupport and internationally accredited plants in

India for cost effective generic products. 

Mission To Leverage these world-class resources for

partnership with large international players to jointly exploit the opportunities in the growing, regulated global generics market.

HISTORICAL BACKGROUND OF

GROUP

MANUFACTURING PLANTSLocation

Parwanoo Plant Baddi PlantMasulkhana

Plant

INTRODUCTION ABOUT DIFFERENT DIVISION

Divisions

Medicus

Dr. Morepen

Medipath

DETAILED OPERATIONS OF TRAINING UNIT

Working on Projects and Surveys.

Promotion of brands through Doctors.

Promotion of brands through Print media.

Enabling easy availability of drugs through strong distribution channel.

IMPORTANT INFORMATION

Unit has network that extends to 250

distributors, 2500 top retailers.

It also caters to 9000 Hospitals, 7500 Clinical Laboratories & 1500 Blood Banks.

Largest Producer of Loratadine.

A strong links with 40,000 doctors.

SWOT ANALYSIS OF MOREPEN LABORATORIES

Weakness1.Low brand image.2.Less presence in domestic market.

Opportunity1. To launch new products because of expiry of patents of some of molecules.

Threats1.A Strong competition from other marketing agencies.

SWOT Analysis of Morepen

Laboratories

CARDIO-DIABETIC MANAGEMENT

Cardio-Diabetic Management

Cardiac diseasesDiabetes diseases

Double Jeopardy

OBJECTIVES

To know causes of increasing cardio diabetic problems.

To check the treatment given by doctors in recent cardio-diabetic management.

To identify the factor associated with the promotion of cardio-diabetic management.

NEED OF STUDY

A figure expected to increase to 1.5 billion by 2025 of Cardio-diabetic patients.

Pharmaceutical Company can also play a crucial role in cardiac-diabetic management.

To grab the market of cardiovascular and diabetic drugs.

A lot of expenditure is expected to be made by people in future.

To promote Cardio-diabetic management.

RESEARCH METHODOLOGY

Scope of Study

Scope of research is mainly restricted to the Pharmaceutical Company and Doctors.

Research Design

It constitutes the blueprint for collection, measurement and analysis of data. This study follows the descriptive design.

Sampling

Universe

Doctors especially cardiologist, dibetologist and consulting physicians in the world.

Population

Cardiologist, Dibetologist and Consulting physicians in the New Delhi.

Sampling technique

The selection of Doctors is done on the basis of Convenience Sampling.

Sampling unit

The sampling unit in this report is any cardiologist and dibetologist or consulting physicians in west zone of New Delhi.

Sample size

Sample size is 50.

METHOD OF DATA COLLECTION

PRIMARY DATA

METHOD OF PRIMARY DATA COLLECTION

 

The method followed in obtaining the primary data was through the structured questionnaire.

 

SECONDARY DATA

  METHOD OF SECONDARY DATA COLLECTION:

  Journals and Magazines Internet

GRAPH 4.1 Causes of increasing cardio-diabetic diseases at faster rate. (N=50)

Graph 4.2 Current treatment regimen is sufficient for cardiac patient (N=50).

Graph 4.3 Therapy preferred for cardiac patient. (N=50)

Graph4.4 The combination or one preferred for cardiac patient.

Graph 4.5 The molecule generally preferred by doctor for cardiac patients. (N=50)

Graph 4.6 The brand generally preferred by doctor for their cardiac patient. (N=50)

The brand preferred for cardiac patient (Contd…)

Graph 4.7 The combination or one preferred for diabetic patient. (N=50)

Graph 4.8 The molecules preferred for diabetic patients. (N=50)

Graph 4.9 The brands preferred for diabetic patients. (N=50)

Graph 4.10 Factors considered while referring the brand of medicine.(N=50)

Graph 4.11 Pharma-Company can play crucial role in cardiac-diabetic management

RESULTS AND FINDINGS Cause of increasing cardiac and diabetic disease is

Lack of awareness among patients and patient’s inadequate education.

Combination therapy is preferred most for Cardio-diabetic patient.

Doctors some time lack in knowledge of drugs . Practitioner also take care of combination drugs for

cardio-diabetic patients. Quality is the first preference of doctors while

referring the brand of medicines. Practitioners need consultancy of Pharma-Company

representators time to time.

SUGGESTIONS

Pharma Company can play its role in cardio-diabetic management by Maintaining good quality and reasonable price.

Consulting practioners time to time.

Advertising regarding awareness.

Formation of new molecule through research.

Making the salt written by practioners in this study.

Formation of drugs taking care of combination drugs,differrent agents in a category,

THANK YOU